Cargando…
The role of COVID‐19 survivor status and gender towards neutralizing antibody titers 1, 2, 3 months after Sinovac vaccine administration on clinical‐year medical students in Indonesia
Background: Sinovac was the first vaccine used in Indonesia against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, data regarding the effects of certain variables such as clinical demographics on antibody levels in individuals vaccinated with Sinovac are scarce. This study ai...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507582/ https://www.ncbi.nlm.nih.gov/pubmed/34653654 http://dx.doi.org/10.1016/j.ijid.2021.10.009 |
_version_ | 1784581889264189440 |
---|---|
author | Heriyanto, Rivaldo Steven Kurniawan, Andree Wijovi, Felix Halim, Devina Adella Jodhinata, Claudia Marcella, Elizabeth Susanto, Billy Wibowo, Johan Indrawan, Michele Heryadi, Nadia Khoirunnisa Imanuelly, Michelle Anurantha, Jonathan Juniard Hariyanto, Timotius Ivan Marcellin, Chintya Sinaga, Terry Devita Rizki, Saraswati Anindita Sieto, Novia Siregar, Jeremia Immanuel Lugito, Nata Pratama Hardjo |
author_facet | Heriyanto, Rivaldo Steven Kurniawan, Andree Wijovi, Felix Halim, Devina Adella Jodhinata, Claudia Marcella, Elizabeth Susanto, Billy Wibowo, Johan Indrawan, Michele Heryadi, Nadia Khoirunnisa Imanuelly, Michelle Anurantha, Jonathan Juniard Hariyanto, Timotius Ivan Marcellin, Chintya Sinaga, Terry Devita Rizki, Saraswati Anindita Sieto, Novia Siregar, Jeremia Immanuel Lugito, Nata Pratama Hardjo |
author_sort | Heriyanto, Rivaldo Steven |
collection | PubMed |
description | Background: Sinovac was the first vaccine used in Indonesia against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, data regarding the effects of certain variables such as clinical demographics on antibody levels in individuals vaccinated with Sinovac are scarce. This study aimed to investigate the impact of gender and previous SARS-CoV-2 infection status on neutralizing antibody titers 1, 2, and 3 months after administration of the Sinovac vaccine. Method: A cross-sectional study was conducted from February to May 2021. Data on neutralizing antibody levels, previous SARS-CoV-2 infection status, and gender were retrieved from the monthly quantitative serology evaluation database of Siloam Hospitals Lippo Village, Tangerang, Indonesia. The role of each variable was analyzed using the t-test or Mann-Whitney U test, depending on data distribution. Result: Data from 350 participants were collected for the study. Participants with a history of a positive SARS-CoV-2 RT-PCR test had significantly higher neutralizing antibody titers in the first (144 U/mL, p = 0.036) and second months (144 U/mL, p = 0.005) after vaccination compared with those without a history of positive RT-PCR test. Female participants also had significantly higher neutralizing antibody titers in the first, second, and third months (43 U/mL, 42 U/mL, and 39 U/mL, respectively; p = 0.001, p = 0.002, and p = 0.003, respectively) after vaccination compared to males. Conclusion: COVID-19 survivor status and the female gender were associated with higher neutralizing antibody titers after Sinovac vaccine administration. |
format | Online Article Text |
id | pubmed-8507582 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85075822021-10-13 The role of COVID‐19 survivor status and gender towards neutralizing antibody titers 1, 2, 3 months after Sinovac vaccine administration on clinical‐year medical students in Indonesia Heriyanto, Rivaldo Steven Kurniawan, Andree Wijovi, Felix Halim, Devina Adella Jodhinata, Claudia Marcella, Elizabeth Susanto, Billy Wibowo, Johan Indrawan, Michele Heryadi, Nadia Khoirunnisa Imanuelly, Michelle Anurantha, Jonathan Juniard Hariyanto, Timotius Ivan Marcellin, Chintya Sinaga, Terry Devita Rizki, Saraswati Anindita Sieto, Novia Siregar, Jeremia Immanuel Lugito, Nata Pratama Hardjo Int J Infect Dis Article Background: Sinovac was the first vaccine used in Indonesia against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, data regarding the effects of certain variables such as clinical demographics on antibody levels in individuals vaccinated with Sinovac are scarce. This study aimed to investigate the impact of gender and previous SARS-CoV-2 infection status on neutralizing antibody titers 1, 2, and 3 months after administration of the Sinovac vaccine. Method: A cross-sectional study was conducted from February to May 2021. Data on neutralizing antibody levels, previous SARS-CoV-2 infection status, and gender were retrieved from the monthly quantitative serology evaluation database of Siloam Hospitals Lippo Village, Tangerang, Indonesia. The role of each variable was analyzed using the t-test or Mann-Whitney U test, depending on data distribution. Result: Data from 350 participants were collected for the study. Participants with a history of a positive SARS-CoV-2 RT-PCR test had significantly higher neutralizing antibody titers in the first (144 U/mL, p = 0.036) and second months (144 U/mL, p = 0.005) after vaccination compared with those without a history of positive RT-PCR test. Female participants also had significantly higher neutralizing antibody titers in the first, second, and third months (43 U/mL, 42 U/mL, and 39 U/mL, respectively; p = 0.001, p = 0.002, and p = 0.003, respectively) after vaccination compared to males. Conclusion: COVID-19 survivor status and the female gender were associated with higher neutralizing antibody titers after Sinovac vaccine administration. The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021-12 2021-10-12 /pmc/articles/PMC8507582/ /pubmed/34653654 http://dx.doi.org/10.1016/j.ijid.2021.10.009 Text en © 2021 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Heriyanto, Rivaldo Steven Kurniawan, Andree Wijovi, Felix Halim, Devina Adella Jodhinata, Claudia Marcella, Elizabeth Susanto, Billy Wibowo, Johan Indrawan, Michele Heryadi, Nadia Khoirunnisa Imanuelly, Michelle Anurantha, Jonathan Juniard Hariyanto, Timotius Ivan Marcellin, Chintya Sinaga, Terry Devita Rizki, Saraswati Anindita Sieto, Novia Siregar, Jeremia Immanuel Lugito, Nata Pratama Hardjo The role of COVID‐19 survivor status and gender towards neutralizing antibody titers 1, 2, 3 months after Sinovac vaccine administration on clinical‐year medical students in Indonesia |
title | The role of COVID‐19 survivor status and gender towards neutralizing antibody titers 1, 2, 3 months after Sinovac vaccine administration on clinical‐year medical students in Indonesia |
title_full | The role of COVID‐19 survivor status and gender towards neutralizing antibody titers 1, 2, 3 months after Sinovac vaccine administration on clinical‐year medical students in Indonesia |
title_fullStr | The role of COVID‐19 survivor status and gender towards neutralizing antibody titers 1, 2, 3 months after Sinovac vaccine administration on clinical‐year medical students in Indonesia |
title_full_unstemmed | The role of COVID‐19 survivor status and gender towards neutralizing antibody titers 1, 2, 3 months after Sinovac vaccine administration on clinical‐year medical students in Indonesia |
title_short | The role of COVID‐19 survivor status and gender towards neutralizing antibody titers 1, 2, 3 months after Sinovac vaccine administration on clinical‐year medical students in Indonesia |
title_sort | role of covid‐19 survivor status and gender towards neutralizing antibody titers 1, 2, 3 months after sinovac vaccine administration on clinical‐year medical students in indonesia |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507582/ https://www.ncbi.nlm.nih.gov/pubmed/34653654 http://dx.doi.org/10.1016/j.ijid.2021.10.009 |
work_keys_str_mv | AT heriyantorivaldosteven theroleofcovid19survivorstatusandgendertowardsneutralizingantibodytiters123monthsaftersinovacvaccineadministrationonclinicalyearmedicalstudentsinindonesia AT kurniawanandree theroleofcovid19survivorstatusandgendertowardsneutralizingantibodytiters123monthsaftersinovacvaccineadministrationonclinicalyearmedicalstudentsinindonesia AT wijovifelix theroleofcovid19survivorstatusandgendertowardsneutralizingantibodytiters123monthsaftersinovacvaccineadministrationonclinicalyearmedicalstudentsinindonesia AT halimdevinaadella theroleofcovid19survivorstatusandgendertowardsneutralizingantibodytiters123monthsaftersinovacvaccineadministrationonclinicalyearmedicalstudentsinindonesia AT jodhinataclaudia theroleofcovid19survivorstatusandgendertowardsneutralizingantibodytiters123monthsaftersinovacvaccineadministrationonclinicalyearmedicalstudentsinindonesia AT marcellaelizabeth theroleofcovid19survivorstatusandgendertowardsneutralizingantibodytiters123monthsaftersinovacvaccineadministrationonclinicalyearmedicalstudentsinindonesia AT susantobilly theroleofcovid19survivorstatusandgendertowardsneutralizingantibodytiters123monthsaftersinovacvaccineadministrationonclinicalyearmedicalstudentsinindonesia AT wibowojohan theroleofcovid19survivorstatusandgendertowardsneutralizingantibodytiters123monthsaftersinovacvaccineadministrationonclinicalyearmedicalstudentsinindonesia AT indrawanmichele theroleofcovid19survivorstatusandgendertowardsneutralizingantibodytiters123monthsaftersinovacvaccineadministrationonclinicalyearmedicalstudentsinindonesia AT heryadinadiakhoirunnisa theroleofcovid19survivorstatusandgendertowardsneutralizingantibodytiters123monthsaftersinovacvaccineadministrationonclinicalyearmedicalstudentsinindonesia AT imanuellymichelle theroleofcovid19survivorstatusandgendertowardsneutralizingantibodytiters123monthsaftersinovacvaccineadministrationonclinicalyearmedicalstudentsinindonesia AT anuranthajonathanjuniard theroleofcovid19survivorstatusandgendertowardsneutralizingantibodytiters123monthsaftersinovacvaccineadministrationonclinicalyearmedicalstudentsinindonesia AT hariyantotimotiusivan theroleofcovid19survivorstatusandgendertowardsneutralizingantibodytiters123monthsaftersinovacvaccineadministrationonclinicalyearmedicalstudentsinindonesia AT marcellinchintya theroleofcovid19survivorstatusandgendertowardsneutralizingantibodytiters123monthsaftersinovacvaccineadministrationonclinicalyearmedicalstudentsinindonesia AT sinagaterrydevita theroleofcovid19survivorstatusandgendertowardsneutralizingantibodytiters123monthsaftersinovacvaccineadministrationonclinicalyearmedicalstudentsinindonesia AT rizkisaraswatianindita theroleofcovid19survivorstatusandgendertowardsneutralizingantibodytiters123monthsaftersinovacvaccineadministrationonclinicalyearmedicalstudentsinindonesia AT sietonovia theroleofcovid19survivorstatusandgendertowardsneutralizingantibodytiters123monthsaftersinovacvaccineadministrationonclinicalyearmedicalstudentsinindonesia AT siregarjeremiaimmanuel theroleofcovid19survivorstatusandgendertowardsneutralizingantibodytiters123monthsaftersinovacvaccineadministrationonclinicalyearmedicalstudentsinindonesia AT lugitonatapratamahardjo theroleofcovid19survivorstatusandgendertowardsneutralizingantibodytiters123monthsaftersinovacvaccineadministrationonclinicalyearmedicalstudentsinindonesia AT heriyantorivaldosteven roleofcovid19survivorstatusandgendertowardsneutralizingantibodytiters123monthsaftersinovacvaccineadministrationonclinicalyearmedicalstudentsinindonesia AT kurniawanandree roleofcovid19survivorstatusandgendertowardsneutralizingantibodytiters123monthsaftersinovacvaccineadministrationonclinicalyearmedicalstudentsinindonesia AT wijovifelix roleofcovid19survivorstatusandgendertowardsneutralizingantibodytiters123monthsaftersinovacvaccineadministrationonclinicalyearmedicalstudentsinindonesia AT halimdevinaadella roleofcovid19survivorstatusandgendertowardsneutralizingantibodytiters123monthsaftersinovacvaccineadministrationonclinicalyearmedicalstudentsinindonesia AT jodhinataclaudia roleofcovid19survivorstatusandgendertowardsneutralizingantibodytiters123monthsaftersinovacvaccineadministrationonclinicalyearmedicalstudentsinindonesia AT marcellaelizabeth roleofcovid19survivorstatusandgendertowardsneutralizingantibodytiters123monthsaftersinovacvaccineadministrationonclinicalyearmedicalstudentsinindonesia AT susantobilly roleofcovid19survivorstatusandgendertowardsneutralizingantibodytiters123monthsaftersinovacvaccineadministrationonclinicalyearmedicalstudentsinindonesia AT wibowojohan roleofcovid19survivorstatusandgendertowardsneutralizingantibodytiters123monthsaftersinovacvaccineadministrationonclinicalyearmedicalstudentsinindonesia AT indrawanmichele roleofcovid19survivorstatusandgendertowardsneutralizingantibodytiters123monthsaftersinovacvaccineadministrationonclinicalyearmedicalstudentsinindonesia AT heryadinadiakhoirunnisa roleofcovid19survivorstatusandgendertowardsneutralizingantibodytiters123monthsaftersinovacvaccineadministrationonclinicalyearmedicalstudentsinindonesia AT imanuellymichelle roleofcovid19survivorstatusandgendertowardsneutralizingantibodytiters123monthsaftersinovacvaccineadministrationonclinicalyearmedicalstudentsinindonesia AT anuranthajonathanjuniard roleofcovid19survivorstatusandgendertowardsneutralizingantibodytiters123monthsaftersinovacvaccineadministrationonclinicalyearmedicalstudentsinindonesia AT hariyantotimotiusivan roleofcovid19survivorstatusandgendertowardsneutralizingantibodytiters123monthsaftersinovacvaccineadministrationonclinicalyearmedicalstudentsinindonesia AT marcellinchintya roleofcovid19survivorstatusandgendertowardsneutralizingantibodytiters123monthsaftersinovacvaccineadministrationonclinicalyearmedicalstudentsinindonesia AT sinagaterrydevita roleofcovid19survivorstatusandgendertowardsneutralizingantibodytiters123monthsaftersinovacvaccineadministrationonclinicalyearmedicalstudentsinindonesia AT rizkisaraswatianindita roleofcovid19survivorstatusandgendertowardsneutralizingantibodytiters123monthsaftersinovacvaccineadministrationonclinicalyearmedicalstudentsinindonesia AT sietonovia roleofcovid19survivorstatusandgendertowardsneutralizingantibodytiters123monthsaftersinovacvaccineadministrationonclinicalyearmedicalstudentsinindonesia AT siregarjeremiaimmanuel roleofcovid19survivorstatusandgendertowardsneutralizingantibodytiters123monthsaftersinovacvaccineadministrationonclinicalyearmedicalstudentsinindonesia AT lugitonatapratamahardjo roleofcovid19survivorstatusandgendertowardsneutralizingantibodytiters123monthsaftersinovacvaccineadministrationonclinicalyearmedicalstudentsinindonesia |